440 related articles for article (PubMed ID: 31095586)
1. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
[TBL] [Abstract][Full Text] [Related]
2. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
3. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
[TBL] [Abstract][Full Text] [Related]
4. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.
Bitzan M; Babayeva S; Vasudevan A; Goodyer P; Torban E
Pediatr Nephrol; 2012 Dec; 27(12):2217-26. PubMed ID: 22538781
[TBL] [Abstract][Full Text] [Related]
5. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
6. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
[TBL] [Abstract][Full Text] [Related]
7. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
8. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
[TBL] [Abstract][Full Text] [Related]
9. Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis.
Yang Q; Tang D; Gan C; Bai M; Song X; Jiang W; Li Q; Chen Y; Zhang A; Wang M
Pediatr Nephrol; 2024 Jan; 39(1):149-165. PubMed ID: 37452832
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
11. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
[TBL] [Abstract][Full Text] [Related]
12. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
[TBL] [Abstract][Full Text] [Related]
14. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
15. Focal segmental glomerulosclerosis; why does it occur segmentally?
Nagata M; Kobayashi N; Hara S
Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE
Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
18. De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.
Weng PL; Majmundar AJ; Khan K; Lim TY; Shril S; Jin G; Musgrove J; Wang M; Ahram DF; Aggarwal VS; Bier LE; Heinzen EL; Onuchic-Whitford AC; Mann N; Buerger F; Schneider R; Deutsch K; Kitzler TM; Klämbt V; Kolb A; Mao Y; Moufawad El Achkar C; Mitrotti A; Martino J; Beck BB; Altmüller J; Benz MR; Yano S; Mikati MA; Gunduz T; Cope H; Shashi V; ; Trachtman H; Bodria M; Caridi G; Pisani I; Fiaccadori E; AbuMaziad AS; Martinez-Agosto JA; Yadin O; Zuckerman J; Kim A; ; John-Kroegel U; Tyndall AV; Parboosingh JS; Innes AM; Bierzynska A; Koziell AB; Muorah M; Saleem MA; Hoefele J; Riedhammer KM; Gharavi AG; Jobanputra V; Pierce-Hoffman E; Seaby EG; O'Donnell-Luria A; Rehm HL; Mane S; D'Agati VD; Pollak MR; Ghiggeri GM; Lifton RP; Goldstein DB; Davis EE; Hildebrandt F; Sanna-Cherchi S
Am J Hum Genet; 2021 Feb; 108(2):357-367. PubMed ID: 33508234
[TBL] [Abstract][Full Text] [Related]
19. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
[TBL] [Abstract][Full Text] [Related]
20. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
